Pune,  INDIA
New York, United States , May  30, 2023  (GLOBE NEWSWIRE) -- The Global Digital Dose Inhaler Market Size to grow from USD 2.65 billion in 2021 to USD 5.98 billion by 2030, at a Compound Annual Growth Rate (CAGR) of 15.5% during the forecast period. Get a Sample PDF Brochure: https://www.sphericalinsights.com/request-sample/1938
With the use of a digital dose inhaler, patients can administer themselves by quickly breathing an aerosolized dose of medication into their lungs in accordance with a predetermined dose. Digital inhalers have built-in sensors that track inspiratory flow and identify inhaler use in line with dose management and release. There are many different kinds of digital dose inhalers available on the market, two examples being metric dose inhalers (MDI) and dry powder inhalers (DPI). The most popular dose delivery technique for treating respiratory disorders like asthma, chronic obstructive pulmonary disease (COPD), and others is metered dose inhalers. Inhalation therapy devices like metres that inhalers combined with an e-dose counter, internet-connected and small inhalers, and others are being considerably revolutionised by the growing technological breakthroughs in the market for digital dose inhalers. To increase patient medication adherence and ensure that the right dosage is being given to patients, the major market players are primarily concentrating on connectivity technology. In addition to this, the rising demand for technologically advanced features like patient tracking and seamless data transfer adds the essential components that are projected to speed up market expansion. On the other hand, rising drug costs, expensive device costs, a lack of public understanding about modern asthma treatments and devices, and other factors will restrain market expansion. COVID 19 Impact
The demand for medical products including personal protective equipment like gloves, masks, and protective eyewear has increased since the COVID 19 epidemic broke out. The need for medical supplies continues to rise from both the general public and healthcare professionals due to the growing number of COVID 19 cases around the world. The major market participants have the chance to take advantage of this increase in medical supply demand in order to guarantee a sufficient supply of personal equipment on the international market. In reality, the pandemic has had a favourable effect on the global market for digital dose inhalers. Impacted is the market for digital dose inhalers. Browse key industry insights spread across 212 pages with 124 market data tables and figures & charts from the report on “ Global Digital Dose Inhaler Market Size , Share, and COVID-19 Impact Analysis, By Product (Metered Dose Inhaler, Dry Powder Inhaler), By Type (Branded Medication, Generics Medication), by Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2021 – 2030 " Get Detailed Report Description Here:
Buy Now Full Report: https://www.sphericalinsights.com/checkout/1938
Product Insights
Metered Dose Inhaler segment is dominating the market with the largest market share over the forecast period
On the basis of product, the global digital dose inhaler market is segmented into metered dose inhaler and dry powder inhaler. Among these, metered dose inhaler segment is dominating the market with the largest market share over the forecast period. The growth is ascribed to rising healthcare costs, a rise in chronic heart disease cases, and the accessibility of metered dose inhalers. Additionally, the segmental growth is being boosted by continuous technological advancements in the production of inhalation medications, such as mechanistic pharmacokinetic in electronic monitoring systems and nanotechnology-based formulation in addition to high drug loads with reduced dose sizes. Type Insights
Branded medication segment accounted the largest revenue share over the forecast period
Based on the type, the global digital dose inhaler market is segmented into branded medication and generics medication. Among these, the branded medication segment accounted the largest revenue share over the forecast period. This is a result of rising healthcare spending levels and rising demand for the development of new respiratory medications. In reality, the continued development of inhalation medicines and the rise in the use of branded drug inhalation are both attributed to the estimated penetration rate of these devices in the field of technology. Inquire Before Buying This Research Report: https://www.sphericalinsights.com/inquiry-before-buying/1938
Regional Insights
North America is dominating the market with the largest market share over the forecast period
Over the projected period, North America will dominate the market for digital dose inhalers. The broad understanding of the current high-tech breathing equipment and the intensive research and development activities may be to blame. Furthermore, a rise in the prevalence of respiratory conditions among both the young and the elderly population would encourage market expansion. On the other hand, over the anticipated period, Asia Pacific would have the fastest market expansion. Japan and China are the two main nations selected as hubs for the respiratory devices industry. The global market for digital dose inhalers is expected to grow as a result of a number of important factors, such as the growing weight of an ageing population, an increase in overall healthcare spending, and the rapidly changing nature of the healthcare sector. Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the global market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market. Major vendors in the Global Digital Dose Inhaler Market include Glenmark Pharmaceuticals Ltd., Novartis AG, Propeller Health, AstraZeneca Plc, Philips Respironics, Opko Health, Inc., Teva Pharmaceutical Industries Ltd., Gecko Health Innovations, Inc., Koninklijke Phillips N.V., GlaxoSmithKline Plc., AptarGroup Inc., Cipla, Inc. and among others. Get Discount At @ https://www.sphericalinsights.com/request-discount/1938
Market Segment
This study forecasts revenue at global, regional, and country levels from 2019 to 2030. Spherical Insights has segmented the global Digital Dose Inhaler Market based on the below-mentioned segments:
Digital Dose Inhaler Market, Product Analysis
Metered dose inhaler
Branded Medication
North America

Global Digital Dose Inhaler Market Size To Grow USD 5.98 Billion By 2030 | CAGR of 15.5%

News Provided By
Share This Article
Intelligent Asthma Monitoring Devices Market 2030
Intelligent asthma monitoring devices market generated $180.5 Mn in 2020, and is projected to reach $1.69 Bn by 2030, witnessing a CAGR of 25.1% - 2021 to 2030
PORTLAND, OREGON, UNITED STATES, March 22, 2023 / EINPresswire.com / -- 𝐈𝐧𝐭𝐞𝐥𝐥𝐢𝐠𝐞𝐧𝐭 𝐀𝐬𝐭𝐡𝐦𝐚 𝐌𝐨𝐧𝐢𝐭𝐨𝐫𝐢𝐧𝐠 𝐃𝐞𝐯𝐢𝐜𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐭𝐚𝐭𝐢𝐬𝐭𝐢𝐜𝐬 𝟐𝟎𝟑𝟎 -
The global intelligent asthma monitoring devices market generated $180.5 million in 2020, and is projected to reach $1.69 billion by 2030, witnessing a CAGR of 25.1% from 2021 to 2030. North America was the leading revenue contributor to the global intelligent asthma monitoring devices market, generating $72.6 million in 2020, and is expected to reach $439.1 million by 2030, registering a CAGR of 23.8% during the forecast period. However, Asia-Pacific is expected to grow at the highest CAGR of 27.3% during the study period, due to increase in affordability, surge in healthcare expenditure, and rise in awareness about intelligent asthma monitoring devices. This is attributed to the early approval of asthma monitoring devices and rapid usage of these devices due to rise in prevalence of asthma and asthma attacks. 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭- https://www.alliedmarketresearch.com/request-sample/5124
𝐂𝐨𝐯𝐢𝐝-𝟏𝟗 𝐬𝐜𝐞𝐧𝐚𝐫𝐢𝐨-
The outbreak of the COVID-19 pandemic has had a positive impact on the global intelligent asthma monitoring devices market. Rise in prevalence rate of chronic respiratory diseases is expected to further drive the growth of the respiratory monitoring devices market in the post pandemic period. 𝐆𝐞𝐭 𝐝𝐞𝐭𝐚𝐢𝐥𝐞𝐝 𝐂𝐎𝐕𝐈𝐃-𝟏𝟗 𝐢𝐦𝐩𝐚𝐜𝐭 𝐚𝐧𝐚𝐥𝐲𝐬𝐢𝐬 - https://www.alliedmarketresearch.com/request-for-customization/5124?reqfor=covid
𝐈𝐧𝐭𝐞𝐥𝐥𝐢𝐠𝐞𝐧𝐭 𝐀𝐬𝐭𝐡𝐦𝐚 𝐌𝐨𝐧𝐢𝐭𝐨𝐫𝐢𝐧𝐠 𝐃𝐞𝐯𝐢𝐜𝐞𝐬 𝐚𝐫𝐞 𝐝𝐞𝐬𝐢𝐠𝐧𝐞𝐝 𝐭𝐨 𝐦𝐨𝐧𝐢𝐭𝐨𝐫 𝐚𝐧𝐝 𝐦𝐚𝐧𝐚𝐠𝐞 𝐚𝐬𝐭𝐡𝐦𝐚 𝐬𝐲𝐦𝐩𝐭𝐨𝐦𝐬 𝐮𝐬𝐢𝐧𝐠 𝐚𝐝𝐯𝐚𝐧𝐜𝐞𝐝 𝐭𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲. 𝐓𝐡𝐞 𝐬𝐞𝐠𝐦𝐞𝐧𝐭𝐬 𝐮𝐬𝐞𝐝 𝐢𝐧 𝐈𝐧𝐭𝐞𝐥𝐥𝐢𝐠𝐞𝐧𝐭 𝐀𝐬𝐭𝐡𝐦𝐚 𝐌𝐨𝐧𝐢𝐭𝐨𝐫𝐢𝐧𝐠 𝐃𝐞𝐯𝐢𝐜𝐞𝐬 𝐦𝐚𝐲 𝐯𝐚𝐫𝐲 𝐝𝐞𝐩𝐞𝐧𝐝𝐢𝐧𝐠 𝐨𝐧 𝐭𝐡𝐞 𝐬𝐩𝐞𝐜𝐢𝐟𝐢𝐜 𝐝𝐞𝐯𝐢𝐜𝐞, 𝐛𝐮𝐭 𝐭𝐲𝐩𝐢𝐜𝐚𝐥𝐥𝐲 𝐢𝐧𝐜𝐥𝐮𝐝𝐞:
Sensors: These are the components that detect and measure a patient's breathing patterns and lung function. The sensors may be located within the device or attached to the patient's body. Data Processing and Analysis: Intelligent Asthma Monitoring Devices use sophisticated algorithms and machine learning to process the data collected by the sensors and analyze changes in lung function that may indicate an asthma attack. Connectivity: Most Intelligent Asthma Monitoring Devices are designed to connect to a smartphone app or cloud-based platform, which allows patients and healthcare providers to access and analyze the data collected by the device. Feedback and Reminders: Many Intelligent Asthma Monitoring Devices provide patients with personalized feedback and reminders to take their medication or use their inhaler as directed. This can help to improve adherence to treatment plans and reduce the risk of asthma attacks. Design and Durability: Intelligent Asthma Monitoring Devices are designed to be small, lightweight, and durable, so that patients can wear them comfortably and without interference with their daily activities. Overall, these segments work together to create an Intelligent Asthma Monitoring Device that can accurately monitor and manage asthma symptoms, providing patients with real-time information and personalized feedback to help them better manage their condition. 𝐑𝐞𝐠𝐢𝐨𝐧𝐚𝐥 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬:
North America was the leading revenue contributor to the global intelligent asthma monitoring devices market, generating $72.6 million in 2020, and is expected to reach $439.1 million by 2030, registering a CAGR of 23.8% during the forecast period. However, Asia-Pacific is expected to grow at the highest CAGR of 27.3% during the study period, due to increase in affordability, surge in healthcare expenditure, and rise in awareness about intelligent asthma monitoring devices. This is attributed to the early approval of asthma monitoring devices and rapid usage of these devices due to rise in prevalence of asthma and asthma attacks. North America  (U.S., Canada, Mexico)
Europe  (Germany, France, UK, Italy, Rest of Europe)
Asia-Pacific  (Japan, China, India, Australia, Rest of Asia-Pacific)
LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲- https://www.alliedmarketresearch.com/purchase-enquiry/5124
𝐏𝐫𝐨𝐦𝐢𝐧𝐞𝐧𝐭 𝐦𝐚𝐫𝐤𝐞𝐭 𝐩𝐥𝐚𝐲𝐞𝐫𝐬-
Adherium, AstraZeneca PLC, Cohero Health, Inc., GlaxoSmithKline plc, Health Care Originals, Koninklijke Philips N.V.,, PROPELLER HEALTH, Teva Pharmaceutical Industries Ltd. (Gecko Health Innovations), Vectura Group plc, Volansys Technologies
𝐀𝐛𝐨𝐮𝐭 𝐀𝐥𝐥𝐢𝐞𝐝 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI. David Correa

Intelligent Asthma Monitoring Devices: Advancements in Sensor Technology and Growing Prevalence of Asthma Drive Growth

Global Smart Inhalers Market Share, Trends and Growth Analysis by Type (Dry Powder Inhaler and Metered Dose Inhaler), Application (Asthma, Chronic Obstructive Pulmonary Disease and others), End User (Hospitals & Clinics, Respiratory Care Centers and others) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2025
Global Smart Inhalers Market   - Overview
Smart Inhaler is a part of new age digital technology which is designed to improve the disease management in the respiratory diseases. Smart Inhalers are basically the respiratory inhalers equipped with a digital sensor. The sensor installed in the inhaler tracks the data such as the dosage timing, monitors the use of the inhaler, and schedules the next dosage. Smart Inhalers can generate alerts for the daily dosage for the user using the smart devices connected to the sensors via Bluetooth. Smart inhaler technology is quickly becoming one of the most valuable areas of pharmaceutical engagement in digital health. There has been rise in number of companies that are adopting this digital technology and opting to use it to enhance the management of lung disorders such as asthma and chronic obstructive pulmonary disorder (COPD), as well as improve the efficacy of the prescribed medications. Wide variety of benefits ranging from improving medication adherence to reducing hospital admissions, which makes smart inhalers the next big thing of respiratory care segment. The global market for smart inhalers is growing continuously and expected to grow at a CAGR of 42.8% during the forecast period 2017-2023. According to a recent study report published by the Market Research Future, The global smart inhalers market is booming and expected to gain prominence over the forecast period growing rapidly. The market is forecasted to demonstrate a spectacular growth by 2023, surpassing its previous growth records in terms of value with a prominent CAGR during the anticipated period (2017 – 2023). Smart inhalers market has been driven by various factors including their advantage over conventional inhalers technological advancements, improving adherence to inhalers, linking with telehealth, and also due to extensive use of smart computing devices. Due to these reasons the market is expected to rise further in the coming future. Simultaneously other factors restricting the market growth includes data security concern related to security devices, regulating government policies for the use of healthcare devices, and also limited availability of these products in potential emerging market and regions. Global Smart Inhalers Market - Competitive Analysis
The market for smart inhalers is characterised by the presence of several well-established and small players, the Global market of smart inhalers appears to be highly competitive and fragmented. Major players are increasingly expanding their footprint in the emerging nations, making it putting pressure on the regional players, especially in terms of features such as type, product portfolios, and pricing. The market is witnessing intensified competition which is expected to get more intensified further during the forecast period. There has been rise in number of companies that are adopting this digital technology and opting to use it to enhance the management of lung disorders such as asthma and chronic obstructive pulmonary disorder (COPD), as well as improve the efficacy of the prescribed medications. For instance, Adherium’s partnering and market expansion for the ‘Rest of World’ territories, including countries in Asia Pacific and the Middle East where Adherium already has sanctions to market its Smartinhaler products in China, Australia and New Zealand. This will increase the company’s strength in these countries. Access Report Details @   https://www.marketresearchfuture.com/reports/smart-inhalers-market-2117
The report for Global market by Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a clear picture of the current market scenario which includes past and estimated future market size with respect to value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information about and strategies used by top key players in the industry. The report also gives a broad study of the different market segments and regions. Key Players:
Adherium Limited (New Zealand), AstraZeneca (England), Cohero Health (USA), GlaxoSmithKline (U.K.), Gecko Health Innovations Inc (USA), Inspiro Medical Ltd., and Propeller Health (USA) are some of the prominent players at the forefront of competition in the Global Smart Inhalers Market and are profiled in MRFR Analysis. About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members. Contact Us:

Global Smart Inhalers Market Technologies, Devices, Healthcare Trends and Market Size in 2020

Global Smart Inhalers Market: Snapshot
Smart inhalers are increasingly becoming the preferred course of managing and treating respiratory diseases. An increasing number of companies are implementing digital technologies in their products to provide an enhanced way of managing asthma and chronic obstructive pulmonary disease (COPD), as well as improving the effectiveness of medication. A number of products are already available in the market and several new products are expected to receive approvals and hit the global market in the next few years. The company Propeller Health (Madison, Wisc) has made inroads in the smart inhalers market through a new FDA-approved mobile platform that monitors and measures when patients take their medicines. The Propeller smart inhaler system includes sensors that are attached to an asthma inhaler, mobile applications, and an analytical system to help patients keep a track of their medication use. AstraZeneca has collaborated with the New Zealand-based company Adherium Limited that manufactures a line of medical devices named Smartinhaler. The Adherium products help the patient track the use of the prescribed medicine and provides audio and visual alerts to remind the patient about a missed dose. Several other companies, including Gecko Health Innovations, Cohero Health, and Opko Health, are working on smart inhalers and the market is soon expected to become competitive in terms of product features and reliability. Looking at the high rate of prevalence of respiratory diseases among the world population and the constant rise in air pollution in developing economies, the demand for smart inhalers is expected to see an upward trend in the next few years. Request Sample Copy of the Report @
Global Smart Inhalers Market: Overview
Smart inhalers refer to the futuristic devices that enable the easy tracking of the consumption amount/volume of medicines prescribed to asthma or chronic obstructive pulmonary disease (COPD) patients through inherent sensors or normal inhalers or nebulizers with clip-on sensors attached externally. Smart inhalers are garnering increased prominence across the globe owing to their many potential benefits over conventional devices, chiefly in terms of tracking drug intake with the help of digital data gathered from the sensor and alerting patients through timely notifications. This report on the global smart inhalers market presents a detailed overview of the market’s present state of growth dynamics and includes several predictions regarding its scope of growth over the period between 2017 and 2025. The report segments the market on the basis of a number of criteria to give an expansive account of top areas of investment offered by the market. A geography-based analysis of the market is also presented to allow the reader a clear understanding of the most profitable regional markets. The report presents a detailed analysis of the key factors expected to have a significant influence on the overall growth prospects of the market in the future years, including growth drivers, restraints, challenges, trends, and opportunities. Forward-looking statements presented in the study are backed with vast qualitative and quantitative details about the market and its key segments. Global Smart Inhalers Market: Drivers and Restraints
For asthma and COPD patients, inhalation is considered the most effective route of delivering medications in the fastest possible time to the respiratory system. Thus, asthma and COPD patients are prescribed with medications that can be delivered through specialized devices called inhalers. In order to mitigate the possibility of undergoing medical complications due to missed dose for an indication, smart inhalers have been devised. Request TOC of the Report @
These connectible devices alert patients about forgotten or missed dosages through notifications on a device connected with the smart inhaler, such as a mobile computing device. Rising awareness about this novel approach in the management of asthma and COPD is expected to be the key factor driving the global smart inhalers market in the next few years. The market for smart inhalers is also expected to be driven due to the rising incidences of respiratory disorders such as COPD and asthma, chiefly owing to rising levels of air pollution and the continuously rising number of smokers across the globe. However, factors such as the high cost of treatment of asthma and COPD, the non-availability of many product varieties, and limited availability of products across several regional markets are expected to hinder the overall growth prospects of the market to a certain extent. General data security concerns associated with connected devices is also expected to limit the adoption of smart inhalers to a certain extent. Global Smart Inhalers Market: Regional and Competitive Dynamics
The global smart inhalers market is presently dominated by North America, which accounted for a dominant share in terms of revenue contribution to the global market in 2016. A significant rise in the patient-base of COPD and asthma, encouraging government initiatives, and high acceptance of innovative and advanced technology allow North America to take the lead in the global market. The extensive use of smart computing devices has also enabled the North America smart inhalers market to become an early adopter of smart inhalers. In the next few years, Asia Pacific is expected to emerge as one of the key regional markets for smart inhalers owing to a rising population of affluent patients, increasing expenditure on healthcare, and rising prevalence of respiratory disorders. Some of the leading companies operating in the global smart inhaler market are Adherium, Teva Pharmaceutical Industries Ltd., Propeller Health, AstraZeneca plc, Boehringer Ingelheim GmbH, Adherium Limited, Vectura Group plc, Cohero Health, LLC, GlaxoSmithKline plc, Novartis AG, OPKO Health, Inc., and Propeller Health. Read Comprehensive Overview of Report @
About TMR Research
TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends. Our savvy custom-built reports span a gamut of industries such as pharmaceuticals, chemicals and metals, food and beverages, and technology and media, among others. With actionable insights uncovered through in-depth research of the market, we try to bring about game-changing success for our clients. Contact:

Smart Inhalers Market 2017-2025 : Cohero Health, LLC, GlaxoSmithKline plc, Novartis AG, OPKO Health, Inc., and Propeller Health

4 minutes read
Global Smart Inhalers Market: Snapshot
Smart inhalers are increasingly becoming the preferred course of managing and treating respiratory diseases. An increasing number of companies are implementing digital technologies in their products to provide an enhanced way of managing asthma and chronic obstructive pulmonary disease (COPD), as well as improving the effectiveness of medication. A number of products are already available in the market and several new products are expected to receive approvals and hit the global market in the next few years. The company Propeller Health (Madison, Wisc) has made inroads in the smart inhalers market through a new FDA-approved mobile platform that monitors and measures when patients take their medicines. The Propeller smart inhaler system includes sensors that are attached to an asthma inhaler, mobile applications, and an analytical system to help patients keep a track of their medication use. AstraZeneca has collaborated with the New Zealand-based company Adherium Limited that manufactures a line of medical devices named Smartinhaler. The Adherium products help the patient track the use of the prescribed medicine and provides audio and visual alerts to remind the patient about a missed dose. Several other companies, including Gecko Health Innovations, Cohero Health, and Opko Health, are working on smart inhalers and the market is soon expected to become competitive in terms of product features and reliability. Looking at the high rate of prevalence of respiratory diseases among the world population and the constant rise in air pollution in developing economies, the demand for smart inhalers is expected to see an upward trend in the next few years. Request Sample Copy of the Report @
Global Smart Inhalers Market: Overview
Smart inhalers refer to the futuristic devices that enable the easy tracking of the consumption amount/volume of medicines prescribed to asthma or chronic obstructive pulmonary disease (COPD) patients through inherent sensors or normal inhalers or nebulizers with clip-on sensors attached externally. Smart inhalers are garnering increased prominence across the globe owing to their many potential benefits over conventional devices, chiefly in terms of tracking drug intake with the help of digital data gathered from the sensor and alerting patients through timely notifications. This report on the global smart inhalers market presents a detailed overview of the market’s present state of growth dynamics and includes several predictions regarding its scope of growth over the period between 2017 and 2025. The report segments the market on the basis of a number of criteria to give an expansive account of top areas of investment offered by the market. A geography-based analysis of the market is also presented to allow the reader a clear understanding of the most profitable regional markets. The report presents a detailed analysis of the key factors expected to have a significant influence on the overall growth prospects of the market in the future years, including growth drivers, restraints, challenges, trends, and opportunities. Forward-looking statements presented in the study are backed with vast qualitative and quantitative details about the market and its key segments. Global Smart Inhalers Market: Drivers and Restraints
For asthma and COPD patients, inhalation is considered the most effective route of delivering medications in the fastest possible time to the respiratory system. Thus, asthma and COPD patients are prescribed with medications that can be delivered through specialized devices called inhalers. In order to mitigate the possibility of undergoing medical complications due to missed dose for an indication, smart inhalers have been devised. These connectible devices alert patients about forgotten or missed dosages through notifications on a device connected with the smart inhaler, such as a mobile computing device. Rising awareness about this novel approach in the management of asthma and COPD is expected to be the key factor driving the global smart inhalers market in the next few years. The market for smart inhalers is also expected to be driven due to the rising incidences of respiratory disorders such as COPD and asthma, chiefly owing to rising levels of air pollution and the continuously rising number of smokers across the globe. Request TOC of the Report @
However, factors such as the high cost of treatment of asthma and COPD, the non-availability of many product varieties, and limited availability of products across several regional markets are expected to hinder the overall growth prospects of the market to a certain extent. General data security concerns associated with connected devices is also expected to limit the adoption of smart inhalers to a certain extent. Global Smart Inhalers Market: Regional and Competitive Dynamics
The global smart inhalers market is presently dominated by North America, which accounted for a dominant share in terms of revenue contribution to the global market in 2016. A significant rise in the patient-base of COPD and asthma, encouraging government initiatives, and high acceptance of innovative and advanced technology allow North America to take the lead in the global market. The extensive use of smart computing devices has also enabled the North America smart inhalers market to become an early adopter of smart inhalers. In the next few years, Asia Pacific is expected to emerge as one of the key regional markets for smart inhalers owing to a rising population of affluent patients, increasing expenditure on healthcare, and rising prevalence of respiratory disorders. Some of the leading companies operating in the global smart inhaler market are Adherium, Teva Pharmaceutical Industries Ltd., Propeller Health, AstraZeneca plc, Boehringer Ingelheim GmbH, Adherium Limited, Vectura Group plc, Cohero Health, LLC, GlaxoSmithKline plc, Novartis AG, OPKO Health, Inc., and Propeller Health. Read Comprehensive Overview of Report @
About TMR Research
TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends. Our savvy custom-built reports span a gamut of industries such as pharmaceuticals, chemicals and metals, food and beverages, and technology and media, among others. With actionable insights uncovered through in-depth research of the market, we try to bring about game-changing success for our clients. Contact:

Smart Inhalers Market Drivers and Restraints 2017-2025 : Boehringer Ingelheim GmbH, Adherium Limited, Vectura Group plc, Cohero Health, LLC

Wellinks

Just Eat

Teva

Healthbox

Healarium

athenahealth

Israeli Air Force

Acquired

Gecko Health Innovations is focused on developing software and product solutions to aid in compliance and adherence improvement in the management of respiratory diseases.

Date	9/25/2015
Round	Acquired
Amount
Investors	Teva
Valuation	$XXM
Revenue	0 FY undefined
Sources	2

First funding	9/25/2015
Last Funding	9/25/2015
Investor	Teva
Rounds	1 Acquired
Board Seats
Type	Corporation
Location	Israel

How VCs Use CB Insights

Professional Services

Platform Overview

Gecko Health Innovations

Investors Count

Funding, Valuation & Revenue

Gecko Health Innovations Investors